The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
Abstract
As our knowledge of type 1 (insulin-dependent) diabetes increases, so does our appreciation for the pathogenic complexity of this disease and the challenges associated with its treatment. Many new concepts about the pathogenesis of this disorder have arisen. The role of genetics versus environment in disease formation has been questioned, and the basis on which type 1 diabetes is characterised and diagnosed is the subject of much debate. Additionally, the care and treatment of patients with type 1 diabetes has seen a rapid evolution; with genetically engineered insulins, glucose monitoring devices, and algorithms all contributing to a decrease in disease-related complications. We focus this seminar on these changing views, and offer a new perspective on our understanding of the pathogenesis of type 1 diabetes and on principles for therapeutic management of patients with this disorder.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Multiple non-HLA loci also contribute to type 1 diabetes risk (387,402).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [402]
In the citing paper
“A model originally posed in 1986,77 updated in our 2001 article,78 and modified subsequently, poses that individuals are born with various degrees of genetic susceptibility for type 1 diabetes.”
From Type 1 diabetes (2014) · cites this paper as [78]
In the citing paper
“HLA-DQ genes appear to be central to the HLA-associated risk of type 1 diabetes, albeit HLA-DR genes may be independently involved [for reviews, see (279,280)].”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [279]
In the citing paper
“No therapeutic intervention that will prevent diabetes has been identified (279,280).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [279]
In the citing paper
“Multiple non-HLA loci also contribute to susceptibility to type 1 diabetes (279).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [279]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue
Lee, H. C., Kim, S.-J., Kim, K.-S., Shin, H.-C., & Yoon, J.-W. (2000) · Nature · doi:10.1038/35044106 · Cited by 434
Retracted(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Shapiro, A. M. J., Lakey, J. R. T., Ryan, E. A., Korbutt, G. S., Toth, E., Warnock, G. L., Kneteman, N. M., & Rajotte, R. V. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007273430401 · Cited by 5,237
Eisenbarth (1986) · doi:10.1056/nejm198605223142106 · Cited by 1,659
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
ISLET-CELL ANTIBODIES IN DIABETES MELLITUS WITH AUTOIMMUNE POLYENDOCRINE DEFICIENCIES
Bottazzo, G., Florin-Christensen, A., & Doniach, D. (1974) · The Lancet · doi:10.1016/s0140-6736(74)90140-8 · Cited by 1,469
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
Epstein, F. H., Atkinson, M. A., & Maclaren, N. K. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411243312107 · Cited by 1,078
Self-citationOnkamo, P., Väänänen, S., Karvonen, M., & Tuomilehto, J. (1999) · Diabetologia · doi:10.1007/s001250051309 · Cited by 892
Nistico, L. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.7.1075 · Cited by 809
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Research works printed but not linked: 4
- Kimpimaki, 2000, Disease-associated autoantibodies as surrogate markers of type 1 diabetes in young children at increased genetic risk. Childhood Diabetes in Finland Study Group, J Clin Endocrinol Metab, 85, 1126
- Turner, 1997, UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group, Lancet, 350, 1288, 10.1016/S0140-6736(97)03062-6 · DOI · Paper page
- Seissler, 1998, Immunological heterogeneity in type 1 diabetes: presence of distinct autoantibody patterns in patients with acute onset and slowly progressive disease, Diabetologia, 41, 891, 10.1007/s001250051004 · DOI
- Verge, 1998, Combined use of autoantibodies (IA-2ab, Gadab, IAA, ICA) in type 1 diabetes: Combinatorial islet autoantibody workshop, Diabetes, 47, 1857, 10.2337/diabetes.47.12.1857 · DOI · Paper page
Cited by
Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60591-7 · Cited by 2,931
Self-citationKatsarou, A., Gudbjörnsdottir, S., Rawshani, A., Dabelea, D., Bonifacio, E., Anderson, B. J., Jacobsen, L. M., Schatz, D. A., & Lernmark, Å. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.16 · Cited by 1,475
The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives
Tsalamandris, S., Antonopoulos, A. S., Oikonomou, E., Papamikroulis, G.-A., Vogiatzi, G., Papaioannou, S., Deftereos, S., & Tousoulis, D. (2019) · European Cardiology Review · doi:10.15420/ecr.2018.33.1 · Cited by 1,381
Sacks, D. B., Arnold, M., Bakris, G. L., Bruns, D. E., Horvath, A. R., Kirkman, M. S., Lernmark, A., Metzger, B. E., & Nathan, D. M. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2010.161596 · Cited by 1,360
The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality: A Randomized Clinical Trial
Anthonisen, N. R., Skeans, M. A., Wise, R. A., Manfreda, J., Kanner, R. E., Connett, J. E., & for the Lung Health Study Research Group* (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-4-200502150-00005 · Cited by 1,237
Metadata
- Authors
- Atkinson, M. A., & Eisenbarth, G. S.
- Affiliations
- University of Florida Health (US)
- University of Colorado Health (US)
- Corresponding author
- Atkinson, Mark A
- ORCID
- Atkinson, Mark A
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2001-07
- Volume
- 358
- Issue
- 9277
- Pages
- 221-229
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2001295992
- Semantic Scholar
- 24a19912850c7e8fc3b28ccec20c2cef16def5c1
- Cited by
- 1,491
- References
- 99
- Citations by year
- 2026: 18 · 2025: 34 · 2024: 41 · 2023: 43 · 2022: 45 · 2021: 50 · 2020: 51 · 2019: 56 · 2018: 60 · 2017: 59 · 2016: 59 · 2015: 53 · 2014: 90 · 2013: 85 · 2012: 83
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Keywords
- type 1 diabetes, pathogenesis, genetic and environmental factors, diabetes diagnosis, glucose monitoring devices, diabetes treatment, diabetes complications
- MeSH terms
- Adult, Autoantibodies, Autoimmune Diseases, Child, Diabetes Mellitus, Type 1, Humans, Insulin, Blood Glucose Self-Monitoring, Incidence, Islets of Langerhans Transplantation, Age of Onset, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Type 1 diabetes: new perspectives on disease pathogenesis and treatment. https://app.cochat.ai/papers/10.1016/s0140-6736(01)05415-0
- The paper
- Atkinson, M. A., & Eisenbarth, G. S. (2001). Type 1 diabetes: new perspectives on disease pathogenesis and treatment. The Lancet. https://doi.org/10.1016/s0140-6736(01)05415-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.